IL6 and immune system disorder: TET2 has various mechanisms in neoplastic and immune diseases and downregulates the expression of inflammatory cytokines IL-6 and IL-1β through recruiting HDAC enzymes for histone deacetylation in innate myeloid cells and macrophages (9).